Home/Filings/4/0000899243-19-028968
4//SEC Filing

F2 - TPO Investments LLC 4

Accession 0000899243-19-028968

CIK 0001750019other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:09 PM ET

Size

40.0 KB

Accession

0000899243-19-028968

Insider Transaction Report

Form 4
Period: 2019-12-09
Jovan-Embiricos Morana
Director10% Owner
Transactions
  • Sale

    Common Stock

    2019-12-10$17.62/sh10,135$178,611433,700 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-10$17.62/sh7,741$136,421331,292 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-09$17.65/sh75,067$1,325,0151,334,504 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-10$17.62/sh30,475$537,0671,304,029 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-11$17.65/sh1,381$24,378432,319 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-09$17.65/sh20,886$368,661371,299 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-09$17.65/sh24,966$440,677443,835 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-11$17.65/sh1,155$20,389361,665 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-11$17.65/sh4,153$73,3111,299,876 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-09$17.65/sh19,070$336,606339,033 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-10$17.62/sh8,479$149,427362,820 total(indirect: By Fund)
  • Sale

    Common Stock

    2019-12-11$17.65/sh1,054$18,606330,238 total(indirect: By Fund)
Holdings
  • Common Stock

    (indirect: By Fund)
    193,742
  • Common Stock

    (indirect: By Fund)
    90,026
  • Common Stock

    (indirect: By Fund)
    175,554
Footnotes (7)
  • [F1]The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F2]The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F3]The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F4]The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F5]The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F6]The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
  • [F7]The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001767397

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:09 PM ET
Size
40.0 KB